4.3 Article

CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 183, Issue 1-2, Pages 60-68

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2006.11.009

Keywords

copolymer-1; MPTP; immunomodulation; neuroprotection; CD4(+) T cells; Parkinson's disease

Funding

  1. NCRR NIH HHS [P20 RR15635] Funding Source: Medline
  2. NIMH NIH HHS [5 P01 MH64570-03] Funding Source: Medline
  3. NINDS NIH HHS [1T32 NS07488, 2R37 NS36126, 1R21 NS049264, 1 P01 NS043985-01] Funding Source: Medline

Ask authors/readers for more resources

Adoptive transfer of lymphoid cells from Copolymer 1 (Cop-1) immunized mice leads to T cell accumulation within the substantia nigra, modulation of microglial responses, upregulation of glial cell derived neurotrophic factor, and protection of the nigrostriatum following 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP) intoxication. We now demonstrate that T cells isolated from lymph nodes and spleens of Cop-1 immunized animals protect the nigrostriatal system from MPTP-induced neurodegeneration in a dose-dependent manner. CD4+ T cells elicited the most significant neuroprotective response while high titers of anti-Cop-1 antibodies showed no effect. These data further support the use of immunomodulatory strategies for Parkinson's disease. (c) 2006 Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available